Trial intelligence / Profile preview

PecFent for Breakthrough Pain During Gastrostomy

NCT02869321Phase 4Completed

Sponsor
CHRU de Nancy - Hôpital Central
Start
May 2015
Primary completion
May 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fentanyl in breakthrough pain, sponsored by CHRU de Nancy - Hôpital Central. Started May 2015; status: completed.

02

Drugs

fentanyl
03

Conditions

breakthrough pain

Beyond the preview

Go deeper on NCT02869321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02869321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call